I worked on different types of slaps at my tournament this weekend. Proud to be a member of this team and looking forward to our last tournament in Georgia next weekend!
The intriguing case for GIPR antagonism, supported by genetics, pharmacology and Maritide is presented by Rosenkilde, George, Veniant and Holst #weightloss ##obesity https://t.co/BRYzffz2gU @Diabetes_ADA@AmDiabetesAssn
As we head to the 2025 @AmDiabetesAssn GIP biology will be part of the conversation. Here Samms and Sloop summarize the compelling scientific story of Tirzepatide and the case for GIPR co-agonism #Diabetes#Weightloss#obesity https://t.co/M5UMnAsl0w
@PaulTitchenell@kaheaisu@jclinicalinvest Really nice work Paul. I really like the use of physiological feeding as an intervention. Have you thought about how glucagon touches this pathway and the impact on glycogen?
https://t.co/syG4uT7TLf
Your fat cells listen and talk. Here, you can read about how surrounding stromal cells in adipose tissue are also getting in on the conversation. New review from @jessicacannavi1@DukeMPI@dukeendocrinol1
“Signs of glucagon resistance after a two-week hypercaloric diet intervention”
#T2D#Pathophysiology
Huge amount of experimental work, facinating results and data-driven conclusions beautifully presented by @MalteSuppli in Hamburg Hall #EASD2023🎯🤩👏🏼
https://t.co/1QN7kmWvTt